Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Novel CCR3 receptor antagonists identified by Toray and Yamanouchi team

July 18, 2003

Patient dosing begins in Targeted Genetics' largest CF trial to date

July 17, 2003

New tachykinin NK1 antagonists prepared and tested at Schering-Plough

July 16, 2003

Updated GOLD guidelines for COPD treatment include first-line tiotropium

July 11, 2003

Safety of Sch-55700 in patients with severe persistent asthma

July 10, 2003

New adenosine A1 and/or A3 receptor antagonists under study at OSI

July 7, 2003

New cPLA2 inhibitors and their use reported by Wyeth in recent patent

July 4, 2003

Chiesi files IND to advance Formoterol Modulite into clinic

July 4, 2003

In vitro and in vivo profile of new orally active histamine H3 antagonist

July 2, 2003

Enrollment completed in phase II trial of SRP-299 for asthma

July 2, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...